These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25306432)

  • 1. Endocrine disruptive compounds and cardio-metabolic risk factors in children.
    Khalil N; Chen A; Lee M
    Curr Opin Pharmacol; 2014 Dec; 19():120-4. PubMed ID: 25306432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
    Wan MLY; Co VA; El-Nezami H
    Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.
    Mohajer N; Du CY; Checkcinco C; Blumberg B
    Front Endocrinol (Lausanne); 2021; 12():780888. PubMed ID: 34899613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Environmental Disruptor Chemicals in the Development of Non Communicable Disease.
    Zarean M; Poursafa P
    Adv Exp Med Biol; 2019; 1121():21-31. PubMed ID: 31392649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment.
    Braun JM
    Nat Rev Endocrinol; 2017 Mar; 13(3):161-173. PubMed ID: 27857130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine Disrupting Chemical Induced "Pollution of Metabolic Pathways": A Case of Shifting Paradigms With Implications for Vascular Diseases.
    Janardhanan R
    Curr Drug Targets; 2018; 19(9):1024-1037. PubMed ID: 29756578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine disruptor compounds in environment: As a danger for children health.
    Beszterda M; Frański R
    Pediatr Endocrinol Diabetes Metab; 2018; 24(2):88-95. PubMed ID: 30300430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal Exposure to Endocrine Disruptors and Reprogramming of Adipogenesis: An Early-Life Risk Factor for Childhood Obesity.
    Shafei AE; Nabih ES; Shehata KA; Abd Elfatah ESM; Sanad ABA; Marey MY; Hammouda AAMA; Mohammed MMM; Mostafa R; Ali MA
    Child Obes; 2018 Jan; 14(1):18-25. PubMed ID: 29019419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol Lett; 2020 Oct; 331():259-264. PubMed ID: 32360654
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic Syndrome and Endocrine Disrupting Chemicals: An Overview of Exposure and Health Effects.
    Haverinen E; Fernandez MF; Mustieles V; Tolonen H
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of endocrine-disrupting chemicals on placental development.
    Yan Y; Guo F; Liu K; Ding R; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1059854. PubMed ID: 36896182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
    Lee DH; Jacobs DR
    J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
    Vandenberg LN; Ågerstrand M; Beronius A; Beausoleil C; Bergman Å; Bero LA; Bornehag CG; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Rudén C
    Environ Health; 2016 Jul; 15(1):74. PubMed ID: 27412149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental impact of the offspring by thyroid hormone system-disrupting environmental chemicals during pregnancy.
    Salazar P; Villaseca P; Cisternas P; Inestrosa NC
    Environ Res; 2021 Sep; 200():111345. PubMed ID: 34087190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review.
    Cano R; Pérez JL; Dávila LA; Ortega Á; Gómez Y; Valero-Cedeño NJ; Parra H; Manzano A; Véliz Castro TI; Albornoz MPD; Cano G; Rojas-Quintero J; Chacín M; Bermúdez V
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.